Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 681313, 11 pages
http://dx.doi.org/10.1155/2015/681313
Review Article

MTHFR C677T Gene Polymorphism and Head and Neck Cancer Risk: A Meta-Analysis Based on 23 Publications

1Department of Stomatology and Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China
2The State Key Laboratory Breeding Base of Basic Science of Stomatology & Key Laboratory of Oral Biomedicine, Ministry of Education, Department of Oral and Maxillofacial Surgery, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China
3Department of Radiology, Taihe Hospital, Hubei University of Medicine, 32 South Renmin Road, Shiyan 442000, China
4Center for Evidence-Based and Translational Medicine, Zhongnan Hospital, Wuhan University, Wuhan 430071, China
5Department of Neurosurgery and Evidence-Based Medicine Center, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China

Received 24 September 2014; Accepted 9 January 2015

Academic Editor: Silvia Persichilli

Copyright © 2015 Yu-Ming Niu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, pp. 2893–2917, 2008. View at Publisher · View at Google Scholar
  3. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. C. R. Ragin, F. Modugno, and S. M. Gollin, “The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus,” Journal of Dental Research, vol. 86, no. 2, pp. 104–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Argiris, M. V. Karamouzis, D. Raben, and R. L. Ferris, “Head and neck cancer,” The Lancet, vol. 371, pp. 1695–1709, 2008. View at Publisher · View at Google Scholar
  6. B. C. Blount, M. M. Mack, C. M. Wehr et al., “Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3290–3295, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Duthie, “Folic acid deficiency and cancer: mechanisms of DNA instability,” British Medical Bulletin, vol. 55, no. 3, pp. 578–592, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Han, Y. Pan, Y. Du et al., “Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and nonsyndromic orofacial clefts susceptibility in a southern Chinese population,” DNA and Cell Biology, vol. 30, no. 12, pp. 1063–1068, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Y. Liu, D. Scherer, E. Poole et al., “Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk,” Molecular Nutrition and Food Research, vol. 57, no. 4, pp. 721–734, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. T. Mayne, H. A. Risch, R. Dubrow et al., “Nutrient intake and risk of subtypes of esophageal and gastric cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 10, pp. 1055–1062, 2001. View at Google Scholar · View at Scopus
  11. P. Frosst, H. J. Blom, R. Milos et al., “A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase,” Nature Genetics, vol. 10, no. 1, pp. 111–113, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. S. J. Weinstein, G. Gridley, L. C. Harty et al., “Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico,” Journal of Nutrition, vol. 132, no. 4, pp. 762–767, 2002. View at Google Scholar · View at Scopus
  13. S. Boccia, P. Boffetta, P. Brennan et al., “Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer,” Cancer Letters, vol. 273, no. 1, pp. 55–61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Little, L. Bradley, M. S. Bray et al., “Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations,” American Journal of Epidemiology, vol. 156, no. 4, pp. 300–310, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Lau, J. P. A. Ioannidis, and C. H. Schmid, “Quantitative synthesis in systematic reviews,” Annals of Internal Medicine, vol. 127, no. 9, pp. 820–826, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. J. P. T. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Mantel and W. Haenszel, “Statistical aspects of the analysis of data from retrospective studies of disease,” Journal of the National Cancer Institute, vol. 22, no. 4, pp. 719–748, 1959. View at Google Scholar
  18. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Kureshi, S. Ghaffar, S. Siddiqui, I. Salahuddin, and P. M. Frossard, “Head and neck cancer susceptibility: a genetic marker in the methylenetetrahydrofolate reductase gene,” Journal for Oto-Rhino-Laryngology and Its Related Specialties, vol. 66, no. 5, pp. 241–245, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A. S. Neumann, H. J. Lyons, H. Shen et al., “Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis,” International Journal of Cancer, vol. 115, no. 1, pp. 131–136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Capaccio, F. Ottaviani, V. Cuccarini, S. Cenzuales, B. M. Cesana, and L. Pignataro, “Association between methylenetetrahydrofolate reductase polymorphisms, alcohol intake and oropharyngolaryngeal carcinoma in northern Italy,” Journal of Laryngology and Otology, vol. 119, no. 5, pp. 371–376, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Vairaktaris, C. Yapijakis, P. Kessler et al., “Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer,” Journal of Cancer Research and Clinical Oncology, vol. 132, no. 4, pp. 219–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Suzuki, K. Matsuo, Y. Hasegawa et al., “One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study,” Cancer Science, vol. 98, no. 9, pp. 1439–1446, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Reljic, A.-M. Simundic, E. Topic, N. Nikolac, D. Justinic, and M. Stefanovic, “The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study,” Clinical Biochemistry, vol. 40, no. 13-14, pp. 981–985, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. T. Hsiung, C. J. Marsit, E. A. Houseman et al., “Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 1, pp. 108–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. R. J. Hung, M. Hashibe, J. McKay et al., “Folate-related genes and the risk of tobacco-related cancers in Central Europe,” Carcinogenesis, vol. 28, no. 6, pp. 1334–1340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. P. R. Solomon, G. S. Selvam, and G. Shanmugam, “Polymorphism in ADH and MTHFR genes in oral squamous cell carcinoma of Indians,” Oral Diseases, vol. 14, no. 7, pp. 633–639, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Ni, J. Tai, L.-J. Ma et al., “Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of laryngeal squamous cell carcinoma,” Chinese Journal of Otorhinolaryngology Head and Neck Surgery, vol. 43, no. 6, pp. 435–438, 2008. View at Google Scholar · View at Scopus
  30. Ł. Kruszyna, M. Lianeri, M. Rydzanicz, M. Gajęcka, K. Szyfter, and P. P. Jagodziński, “Polymorphic variants of folate metabolism genes and the risk of laryngeal cancer,” Molecular Biology Reports, vol. 37, no. 1, pp. 241–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. C.-W. Tsai, C.-F. Hsu, M.-H. Tsai et al., “Methylenetetrahydrofolate reductase (MTHFR) genotype, smoking habit, metastasis and oral cancer in Taiwan,” Anticancer Research, vol. 31, no. 6, pp. 2395–2399, 2011. View at Google Scholar · View at Scopus
  32. G. Supic, N. Jovic, R. Kozomara, K. Zeljic, and Z. Magic, “Interaction between the MTHFR C677T polymorphism and alcohol-impact on oral cancer risk and multiple DNA methylation of tumor-related genes,” Journal of Dental Research, vol. 90, no. 1, pp. 65–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Sailasree, K. R. Nalinakumari, P. Sebastian, and S. Kannan, “Influence of methylenetetrahydrofolate reductase polymorphisms in oral cancer patients,” Journal of Oral Pathology & Medicine, vol. 40, no. 1, pp. 61–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. L. S. Galbiatti, M. T. Ruiz, J. O. Rodrigues et al., “Polymorphisms and haplotypes in methylenetetrahydrofolate reductase gene and head and neck squamous cell carcinoma risk,” Molecular Biology Reports, vol. 39, no. 1, pp. 635–643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. K. Siraj, M. Ibrahim, M. Al-Rasheed et al., “Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population,” BMC Medical Genetics, vol. 9, article 61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. J. O. Rodrigues, A. L. S. Galbiatti, M. T. Ruiz et al., “Polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and risk of head and neck squamous cell carcinoma,” Brazilian Journal of Otorhinolaryngology, vol. 76, no. 6, pp. 776–782, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Cao, X.-P. Miao, M.-Y. Huang et al., “Polymorphisms of methylenetetrahydrofolate reductase are associated with a high risk of nasopharyngeal carcinoma in a smoking population from Southern China,” Molecular Carcinogenesis, vol. 49, no. 11, pp. 928–934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. V. V. T. S. Prasad and H. Wilkhoo, “Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers,” Onkologie, vol. 34, no. 8-9, pp. 422–426, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Fard-Esfahani, A. Fard-Esfahani, P. Saidi, S. Fayaz, R. Mohabati, and M. Majdi, “An increased risk of differentiated thyroid carcinoma in Iran with the 677C→T homozygous polymorphism in the MTHFR Gene,” Cancer Epidemiology, vol. 35, no. 1, pp. 56–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Ozdemir, F. Silan, Z. Hasbek et al., “Increased T-allele frequency of 677 C>T polymorphism in the methylenetetrahydrofolate reductase gene in differentiated thyroid carcinoma,” Genetic Testing and Molecular Biomarkers, vol. 16, no. 7, pp. 780–784, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Vylliotis, C. Yapijakis, E. Nkenke et al., “Effect of thrombosis-related gene polymorphisms upon oral cancer: a regression analysis,” Anticancer Research, vol. 33, no. 9, pp. 4033–4040, 2013. View at Google Scholar · View at Scopus
  42. L. L. Stern, J. B. Mason, J. Selhub, and S.-W. Choi, “Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene,” Cancer Epidemiology Biomarkers and Prevention, vol. 9, no. 8, pp. 849–853, 2000. View at Google Scholar · View at Scopus
  43. K. Kawakami, A. Ruszkiewicz, G. Bennett, J. Moore, G. Watanabe, and B. Iacopetta, “The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase,” Clinical Cancer Research, vol. 9, no. 16, pp. 5860–5865, 2003. View at Google Scholar · View at Scopus
  44. P. Goyette, A. Pai, R. Milos et al., “Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR),” Mammalian Genome, vol. 9, no. 8, pp. 652–656, 1998. View at Google Scholar
  45. R. Rozen, “Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR),” Thrombosis and Haemostasis, vol. 78, no. 1, pp. 523–526, 1997. View at Google Scholar · View at Scopus
  46. T. Mazaki, H. Masuda, and T. Takayama, “Polymorphisms and pancreatic cancer risk: a meta-analysis,” European Journal of Cancer Prevention, vol. 20, no. 3, pp. 169–183, 2011. View at Publisher · View at Google Scholar
  47. S. M. Langevin, D. Lin, K. Matsuo et al., “Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer,” Toxicology Letters, vol. 184, no. 2, pp. 73–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Zhang, L.-X. Qiu, Z.-H. Wang et al., “MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls,” Breast Cancer Research and Treatment, vol. 123, no. 2, pp. 549–555, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. D. A. Kennedy, S. J. Stern, I. Matok et al., “Folate intake, MTHFR polymorphisms, and the risk of colorectal cancer: a systematic review and meta-analysis,” Journal of Cancer Epidemiology, vol. 2012, Article ID 952508, 24 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Zhang, G. Qiang Chen, Y. Ji et al., “Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma,” Molecular Biology Reports, vol. 39, no. 5, pp. 6203–6211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. V. L. Stevens, C. Rodriguez, J. Sun, J. T. Talbot, M. J. Thun, and E. E. Calle, “No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 12, pp. 3612–3614, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. X. Zhuo, J. Ling, Y. Zhou, H. Zhao, Y. Song, and Y. Tan, “Polymorphisms of MTHFR C677T and A1298C association with oral carcinoma risk: a meta-analysis,” Cancer Investigation, vol. 30, no. 6, pp. 447–452, 2012. View at Publisher · View at Google Scholar · View at Scopus